For the Inventor, By the Inventor

Enter assignee name

Serono Genetics Institute S.a.

USPTO Granted Patents = 62

EPO Patents = 2

Forward Citations = 383

Loading Chart...

Loading Chart...

62 inventors (with patents filed for the assignee):

Lydie Bougueleret (25 out of 53 patents)

Bernard Bihain (17 out of 27 patents)

Ilya Chumakov (16 out of 85 patents)

4. Marta Blumenfeld (13 out of 38 patents)

5. Hiroaki Tanaka (12 out of 15 patents)

6. Jean-Baptiste Dumas Milne Edwards (10 out of 23 patents)

7. Stephane Bejanin (9 out of 10 patents)

8. Frances Yen-Potin (8 out of 14 patents)

9. Mary Erickson (6 out of 21 patents)

10. Robert J Zagursky (5 out of 21 patents)

11. Benjamin J Metcalf (5 out of 21 patents)

12. Rémy Griffais (5 out of 7 patents)

13. Susan K Hoiseth (5 out of 7 patents)

14. Joel A Peek (5 out of 10 patents)

15. Banumathi Sankaran (5 out of 7 patents)

Core Competencies:

Lipolysis Stimulated Receptor

Genotyping Methods

Chlamydia Trachomatis

Polymorphic Markers

5-Lipoxygenase-Activating Protein

Leptin Fragment

Schizophrenia Related Protein

KCNQ2-15 Potassium Channel

Metabolic Gene Polynucleotides

OBG3 Globular Head

Nucleic Acids Encoding Proteins

Prostate Cancer Gene

62 patents: Sort by Forward Citations

1. 7919091 - Lipolysis stimulated receptor (LSR) specific antibodies (2011-04-05),

2. 7910329 - [object Object] (2011-03-22),

3. 7838241 - Genotyping methods using genomic sequence of the 5-lipoxygenase-activating protein (FLAP) and polymorphic markers thereof (2010-11-23),

4. 7671024 - OBG3 globular head and uses thereof (2010-03-02),

5. 7601531 - [object Object] (2009-10-13),

6. 7575913 - Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection (2009-08-18),

7. 7547771 - Polymorphic markers of prostate carcinoma tumor antigen -1(PCTA-1) (2009-06-16),

8. 7494777 - Genomic sequence of the 5-lipoxygenase-activating protein (FLAP), polymorphic markers thereof and methods for detection of asthma (2009-02-24),

9. 7470669 - Isolated polypeptide comprising a leptin fragment (2008-12-30),

10. 7459433 - Homotrimeric extended OBG3 globular head and uses thereof (2008-12-02),

11. 7449543 - Schizophrenia related protein (2008-11-11),

12. 7449304 - Method for enhancing the efficiency of an enzymatic process for removal of contaminating nucleotides (2008-11-11),

13. 7442519 - KCNQ2-15 potassium channel (2008-10-28),

14. 7432367 - Nucleic acid encoding a retinoblastoma binding protein (RBP-7) and polymorphic markers associated with said nucleic acid (2008-10-07),

15. 7432056 - Biallelic markers derived from genomic regions carrying genes involved in arachidonic acid metabolism (2008-10-07),

Serono Genetics Institute S.A. is a leading bio-tech company specializing in genetics research and diagnostics. We are committed to improving lives through cutting-edge scientific advancements and personalized medicine. With state-of-the-art laboratories and a team of renowned scientists, we offer a wide range of genetic testing services and develop innovative therapies for genetic disorders. Visit our website to learn more about our groundbreaking work in the field of genetics.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

62 Patents

#1 in Evry

#393 in France

#11,475 in the World

Serono Genetics Institute S.a.

Forward Citations = 383

62 inventors:

Lydie Bougueleret (25 out of 53 patents)

Bernard Bihain (17 out of 27 patents)

Ilya Chumakov (16 out of 85 patents)

4. Marta Blumenfeld (13 out of 38 patents)

5. Hiroaki Tanaka (12 out of 15 patents)

Please report any incorrect information to support@idiyas.com

Loading…